GAIN OF FUNCTION ON POX VIRUSES CONFIRMED
Amazing Polly | May 23, 2022
I cover the US’s leading Orthopox Virus researcher who conducted at least 2 rounds of gain of function research on viruses related to smallpox. Other revelations about bio-terror ‘research’ in here too. Support my work: https://amazingpolly.net/contact-support.php THANKS! References below.
NYT Mousepox Gain of Function: https://www.nytimes.com/2003/11/01/us/bioterror-researchers-build-a-more-lethal-mousepox.html
Buller Says Vaccine for Monkeypox (using smallpox vax) NOT recommended: https://pubmed.ncbi.nlm.nih.gov/17661673
Buller paper on Monkeypox Outbreaks up to 2012: https://pubmed.ncbi.nlm.nih.gov/23626656/
Judicial Watch re James Leduc / Wuhan: https://www.judicialwatch.org/wuhan-lab-fauci-grants/
National Biocontainment Training Center report by Leduc: https://apps.dtic.mil/sti/pdfs/AD1022067.pdf
Concerns of Fraud in Pfizer Vaccine Trial as Participant’s Hospitalisation with Heart Inflammation is Swept Under Carpet
By Will Jones | The Daily Sceptic | May 23, 2022
You may have heard the disturbing story of Maddie de Garay, who in July 2020, aged 12, participated in Pfizer’s Covid vaccine trial of adolescents aged 12-15. Within 24 hours of receiving the second dose in early January 2021, Maddie experienced “zapping pain up and down her spine with severe abdominal pain… her toes and fingers turned white and were ice cold”. She now can barely see, suffers from tinnitus, mobility issues, vomiting, blood in her urine, numbness in her body and has at least 10-20 seizures a day. Yet her injury was recorded in the vaccine trial data as “abdominal pain” and it was asserted without investigation to be not related to the vaccine.
Another case, similarly disturbing, has now emerged of an adverse reaction during a Pfizer trial that was not recorded in the trial data, raising concerns about the integrity of the trial data and the possibility of fraud.
Augusto Roux is a 35-year old lawyer from Buenos Aires, Argentina who volunteered for Pfizer’s Covid vaccine phase 3 trial. He did so to protect his mother, who has emphysema.
On the way home after his second dose on September 9th 2020, he began feeling unwell, developed a high fever and felt very ill. He fainted on September 11th and went to the hospital on September 12th. The hospital ran tests, including a CAT scan of his chest, which showed an abnormal collection of fluid around the outside of the heart, indicating pericarditis (a form of heart inflammation).
On September 14th he was discharged, with the doctor writing in his discharge note that he had suffered an adverse reaction to the vaccine. Augusto was also told by hospital staff that there had been a considerable number of people from the clinical trial coming to the hospital – one nurse estimated staff had seen around 300 people – so his experience was not new to them. Around 3,000 trial participants had been enrolled before Augusto, so, if the nurse’s estimate is accurate, this would be a hospitalisation rate of 10%.
Following his adverse reaction, Augusto asked to see his trial clinical records, but those running the trial refused. Being a lawyer, Augusto went to law to get access to his records, which took over a year. Once he saw them, he could well imagine why someone might not want them to be released.
In hospital, Augusto had tested negative for Covid, and the doctor at the hospital had written that his condition was due to the vaccine. However, when Augusto contacted the trial site on September 14th to notify the investigators he had been in hospital, they wrote down in his clinical trial record that he had been admitted for a “bilateral pneumonia” that had nothing to do with the “investigational product” – the vaccine – even though that was not what he told them or what the doctor who examined him had stated.
For obvious reasons, Augusto was keen to know whether he’d had the vaccine or not. However, the principal investigator for the trial, Fernando Polack (pictured below), had inaccurately claimed that he could only be unblinded if his life were in danger. Augusto appealed to ANMAT, the Argentinian equivalent of the FDA, and following a formal hearing on October 9th 2020 it forced the trial investigators to tell Augusto that he had, indeed, received the vaccine.
The clinical trial notes reveal that two days prior to this hearing, on October 7th, “at the request of the sponsor” (Pfizer), the adverse event code was updated from pneumonia to “COVID-19 disease”. This is despite Augusto testing negative at the time of his admission. (Conveniently for Pfizer, the COVID-19 ‘diagnosis’ would not be included in the trial vaccine efficacy calculations due to the negative test.)
Even more disturbing, on October 8th, Polack wrote in Augusto’s clinical trial records that he had had an attack of “severe anxiety” starting on September 23rd (not caused by the vaccine, naturally). Polack added that Augusto suspected a conspiracy between the two hospitals, described his anxiety as “constitutional”, and noted that it was ongoing, evidenced by his pursuing his appeal to ANMAT. On October 11th, Polack had this mental health diagnosis added to his actual medical records.
Dr. David Healy, who has interviewed Augusto and seen the medical records in question, comments that “there is nothing in any record that indicates that Dr. Polack or any other doctor attempted on September 23rd to establish whether Augusto had a mental disorder”. He adds:
Augusto points to the notes of October 8th and 11th as evidence that this idea was invented just around the time the ANMAT hearing was about to happen. He states that it is in breach of Argentinian law for Dr. Polack to have diagnosed someone with a medical condition that the person does not have – and to have entered it into his medical record.
Note that Polack is a paediatrician so lacks the qualification to make mental health diagnoses, especially without any formal assessment.
Polack is a key player in the Pfizer Covid vaccine trials. He was the lead author on the December 2020 NEJM paper on the safety and efficacy of the vaccine. Israeli academic Josh Guetzkow notes that he is also one of the directors of i-trials, the site management organisation “paid handsomely by Pfizer to run the trial in Argentina (the largest site of the trial by far)”. Guetzkow adds:
If he raised an alarm about the vaccine safety, his company would have lost a ton of money and would be an unlikely choice by any company to run any trials in the future. So to say that he had an interest in achieving a positive trial outcome would be quite an understatement. There may be other conflicts we’re not aware of.
The evidence of malpractice and possible fraud in the Pfizer Covid vaccine trials is certainly stacking up now. But very few people are aware of it as it is mostly only being reported in alternative media. When will mainstream outlets start following up properly on this potentially massive story?
The Rise of Hepatitis
By Carla Peeters | Brownstone Institute | May 23, 2022
The number of previously healthy children younger than 16 years of age with mysterious hepatitis cases have doubled in two weeks to 450 cases worldwide, including 11 deaths. Most cases have been reported in the UK (160) and the US (currently, 180). In Europe most cases are found in Italy (35) and Spain (22). Over 8-14% of the patients needed liver transplantation. These children will be on lifelong medication. Until now the real cause of a sudden spark in hepatitis is not clear.
Although 50-72% of the cases tested positive with a PCR test for Adenovirus, tissue and liver samples taken in the UK do not show any typical features that might be expected with a liver inflammation due to this virus.
In the UK, 18% of the reported cases tested positive for SARS-CoV-2 virus and three cases had tested positive 8 weeks prior to admission. The most plausible cause of hepatitis traces to a viral origin. Brodin and Aditi hypothesize a SARS-CoV-2 superantigen mediated immune activation in an Adenovirus-sensitized host.
At this point many of the children with hepatitis are too young to be eligible for COVID-19 vaccination. So far, no common environmental exposure has been found.
Jaundice is characteristic for all children with hepatitis, which could have many reasons including toxins and malnutrition. A search into the peer-reviewed scientific literature on the toxicology of nanoparticles, microplastics, disinfectants and hypercapnia/hypoxia, children have been extensively exposed to during the pandemic makes bio corona formation and accumulation of toxic substances a reasonable explanation for disruption of the liver homeostasis.
The capacity for excessive activation of liver inflammatory pathways has been described for these materials prior to the pandemic. Effects of the complex mixture of these materials and associated chemical pollutants presented have not yet been assessed. Understanding how these materials interact with its biological surroundings during long-term and frequent exposure is of utmost importance.
Pandemic Measures and Liver Toxicity
Early in the pandemic several researchers warned of the unsafe use of facemasks, tests, and disinfectants and their weakening effect on the immune system. Many institutions are starting research on harmful chemicals due to air pollution as they pose a known threat to public health and the economy, representing 10% of global GDP in health costs and 3.75 billion lost working days at the global level in 2060.
Unfortunately, almost no funded research has been started in the area of the safe, cost/benefit use of the mandates. Instead, during the pandemic large amounts of money were spent on less urgent research on non-pandemic related issues.
While Covid-19 was originally thought to be a respiratory infection, various research papers have indicated myocardial inflammation, hepatitis, or neurological experiences independent of severity of Covid-19 and sometimes without evidence of a viral infection. Other researchers found that cardiac damage was more related to clotting and microthrombi were frequent. Almost 25% of people hospitalized develop myocardial injury and many develop arrhythmias or thromboembolic disease.
Lockdowns, with many people experiencing an ongoing state of fear and anxiety and frequent exposure to nanoparticles, microplastics, high CO2 exposure and toxic substances impaired the innate immune system even more.
Furthermore, several studies have indicated a remarkable suppression of the innate immune system after injections with PEGylated lipid nanoparticle (LNP) modified mRNA vaccines. In vivo studies for cytotoxicity and genotoxicity of these vaccines, prior to their release under EUA and being mandated for many people and children, have been neglected.
Unfortunately, more than two years into the pandemic an alarming stage of mysterious rises in infectious and noncommunicable diseases and sudden non-Covid deaths have been reported, even neonatal deaths. The Observer reported one in three people in the UK are experiencing long-term illness.
The Liver Is an Immune Surveillance System
The liver is an important organ responsible for the storage, synthesis, metabolism and redistribution of carbohydrates, fats and vitamins and numerous essential proteins. It is the main detoxification center of the body. A most important organ for generating an effective innate immune response and covering a robust and long-lasting immunity, it works to keep virus, bacteria and excessive inflammations in check.
About 30% of the total blood passes through the liver every minute and is scanned by the mononuclear phagocytic system (MPS) in the liver. The microenvironment in the liver shapes and functions the antigen specific CD4+ T cell population with the capacity for longevity/self-renewal for more than a decade.
High amounts of CD8, Natural Killer T cells, dendritic cells and macrophages (Kupfer cells) in the liver play an important role in the protective innate immune system during injury and infection deciding for tolerance or excessive inflammation. Specific liver cells, hepatocytes, produce 80-90% of the circulating innate immunity proteins in the body including acute phase proteins, complement, bactericidal proteins and more.
Neutrophils, the most abundant leukocytes in the blood, present in the liver perform important functions in inflammation and act as a functional bridge between the innate and adaptive immunity (B cells and T cells) activating antigen specific immune responses.
Homeostatic inflammation is a normal part of a healthy liver. In the complex microenvironment of the liver, the hepatic immune system tolerates harmless molecules while at the same time remaining alert to possible infectious agents, malignant cells or tissue damage. Inflammatory processes are required to rid itself of pathogens, cancer cells or toxic products of metabolic activity. The inflammatory processes are intimately linked to mechanisms that resolve inflammation and promote tissue regeneration.
Excessive and dysregulated inflammatory activity are key drivers of liver pathology, associated with systemic inflammation: chronic infection, autoimmunity and cancer. Mechanisms to resolve liver inflammation are essential to maintain local organ and systemic homeostasis. It is the balance between activation and tolerance that characterizes the liver as a frontline immunological organ. Disrupting this precious surveillance system increases the risk for severe disease and death.
Immune-Liver Disruptors
A possible role of the pandemic measures in excessive inflammation in the human body by immune-liver disruptors is realistic. Independently they may each cause problems of the liver. Serious drawbacks of the measures have become most visible in children, the obese and immunocompromised and the poor.
Nanoparticles (i.e. inhaled graphene oxide, titanium dioxide, Ag from facemasks or swabs) present in the body are cleared from the blood and will preferentially accumulate and sequester in the liver, up to 30-99% from those present in the blood and at much higher quantities as compared to other organs.
Studies in recent years have shown that nanomaterials can modulate and activate neutrophils and other immune cells. Nanomaterials may be considered as a particular case of danger signals that are able to trigger sterile inflammatory responses. Rapid accumulation of nanoparticles in the resident liver macrophages can change the expression of anti-inflammatory genes. Changes of genes related to detoxification and cell cycle have been observed.
Systematically administered nanoparticles may directly interact with circulating erythrocytes leading to erythrocyte aggregation and or hemolysis that is accompanied by hemoglobin release. Surface properties of the nanoparticles are known to play a critical role in nanoparticle-erythrocyte interaction. Most nanoparticles have been known to activate complements by either themselves or through serum proteins. Activation of complements and complement activation pathways could further promote tumor growth.
Nanoparticles develop a specific bio-corona comprising complex and dynamic layers of biomolecules that endow nanoparticles with a new immunological identity.
Studies on polystyrene microplastics (which can be present in facemasks and swabs) showed hepatotoxicity and dysregulation of the lipid metabolism, causing oxidative stress and inflammatory responses. This implicated a potential risk for liver steatosis, fibrosis and cancer and macrophage foam cell formation, a characteristic feature observed during atherosclerosis posing a serious threat to human health.
Another study demonstrated that fish exposed to a mixture of polyethylene with chemical pollutants bioaccumulate the chemical pollutants and suffer liver toxicity and pathology. Moreover 0.1 um microplastics could enter hepatocytes from circulation and result in liver damage even at a low concentration.
Microplastic exposure could induce DNA damage in both nucleus and mitochondria indicating a potential risk of hepatotoxicity and fibrosis. Microplastics are found in the human blood of 80 % of the people tested, in deep lung tissues and human feces.
Covid-19 mRNA vaccines use Acuitas’ PEG (Poly Ethylene Glycol) ylated lipid nanoparticles (LNP). The PEGylated lipids support prolonged circulation and shield the highly inflammatory and cytotoxic effects of the cationic lipids used. If insufficiently shielded by PEG they have been shown to mediate aggregation and interact with and damage the membranes of erythrocytes resulting in hemolysis. PEG content, surface density and conformation of the nanoparticle influence the binding of proteins to a bio corona and the uptake by immune cells.
Despite achieving high dense surface coatings of PEG, no NP formulation has been developed that can completely resist interaction with blood components. Of concern is that 22-25% of individuals who were never exposed to PEGylated therapeutics were found to have PEG antibodies, which is more than two decades ago. PEG coating can improve the penetration of biological barriers including reducing interactions with tissue extracellular matrix cellular barriers and biological fluids such as mucus leading to improved delivery.
After injection of Moderna LNP very low levels could be detected in the brain, potentially indicating that the mRNA LNP could cross the blood brain barrier and reach the Central Nervous System (CNS). Unfortunately, the potential inflammatory nature of these LNPs was not assessed.
In preclinical studies a strong induction of adaptive immune responses by CD4+ T-cell activation and protective humoral immune responses was found. The synthetic ionizable lipid is speculated to have approximately 20-30 days of half-life in humans. It has been shown that plasma protein absorption occurs very rapidly and that it affects hemolysis, thrombocyte activation, cellular uptake and endothelial cell death. The bio corona formation of the PEGylated nanoparticle may change over time.
The increasing number of side effects and reported high potency for eliciting antibody response may partially stem from the LNP’s highly inflammatory nature characterized by leukocyte infiltration and activation of different inflammatory cytokines and chemokines. Antigen-presenting cells presenting vaccine derived peptides/protein might cause tissue damage and exacerbate side effects, which have been linked to autoimmune diseases.
More severe and systemic side effects after the booster shot might be related to an amplification effect of the adaptive immune response induced by the vaccine resulting in high antibody responses. Neutrophils were found to preferentially internalize PEGylated particles in the presence of human plasma. Also, further studies of complement activation in relation to PEG nanoparticles merit rigorous evaluation for immune safe materials. Observational studies found a greater risk for complications following a positive SARS-CoV-2 test. A study of the University of Lund has indicated by in vitro studies that the BNT162b2mRNA vaccine has a fast take-up into human liver cells. In 6 hours of exposure the RNA was reverse transcribed into DNA.
Sennef et al. describes the disruption of the innate immune system by the Covid-19 mRNA vaccines caused by an impaired interferon signaling, release of large amounts of exosomes containing Spike protein, potential disturbances in regulatory control of protein synthesis and cancer surveillance of and their potential direct link to liver disease (with over 2,000 reports in VAERS December 2021) and other inflammatory diseases. The presence of Spike protein has been detected in the blood and 60 days after mRNA vaccine injection in the lymph nodes.
A functional reprogramming of the innate immune responses after BNT 162b2 injection was also observed by Fohse et al. with a lower response of innate immune cells, while the fungi-induced cytokine responses were stronger. A study on Biovrix by Nguyen et al. demonstrated an impaired lipid metabolism and increased lipotoxicity by the Spike protein. Jiang et al observed that the Spike protein localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein recruitment to a damaged site. A mechanism by which the spike protein might impede the adaptive immunity explaining the potential side effects. Suraswaki et al. stated that the virus itself may dysregulate the innate cellular defenses using various structural and nonstructural proteins.
Taking Back Control of Our Bodies
The European Commission Statement from May 12, 2022, announces to shorten (from 300 to 100 days) the product to market cycle to develop safe and effective vaccines, therapeutics, and diagnostics following the identification of new threats and work to make them widely available.
As discussed, the Covid-19 pandemic measures have shown to be far from safe. All materials are known to interact and bind proteins forming bio corona’s depleting the body of essentials for processes to function properly.
Subtle changes in materials and biological fluids of persons can significantly change the protein composition of the bio corona and can either lead to an excessive inflammation or resilient homeostasis. Especially in children who need more proteins, vitamins and minerals for mental, physical, and immune system development, the accumulation of toxic substances in the liver and formation of bio corona can be a serious threat to health.
At this stage, it is not known whether the mysterious rises in diseases are caused by a virus or an intoxication and/or depletion of essentials that result in impaired signaling routes. The Covid-19 routine diagnostic tests used for mass testing have major flaws which make it impossible to ensure the presence of an infectious virus as a single cause of symptoms.
An increasing number of doctors and researchers agree: the pandemic is over. All pandemic measures need to be halted immediately. The highest priority is lifting the mandates for children. Healthy children always had a very low risk for severe Covid-19 and are protected by a strong robust and long-lasting natural immunity. There is no added value to vaccinate any person with natural immunity. Moreover, the risk for side effects of the mRNA vaccine for children is high. mRNA Covid vaccine accumulates in the liver 30 minutes after it is injected.
Deep investigations on quality, reproducibility and contaminations of the materials of personal protective equipment, facemasks, tests, disinfectants and vaccines, being used with their effects on the human body and the environmental ecosystem need to be prioritized and funded.
During the past two years, the immune system of many people has been harmed and even broken. We need programs to regenerate the liver and immune system so people can face with trust and confidence any possible wave of virus attacks.
Carla Peeters is founder and managing director of COBALA Good Care Feels Better. She obtained a PhD in Immunology from the Medical Faculty of Utrecht, studied Molecular Sciences at Wageningen University and Research, and followed a four-year course in Higher Nature Scientific Education with a specialization in medical laboratory diagnostics and research. She studied at various business schools including London Business School, INSEAD and Nyenrode Business School.
FDA Dumps More Pfizer Documents: Why Were So Many Adverse Events Reported as ‘Unrelated’ to Vaccine?
By Michael Nevradakis, Ph.D. | The Defender | May 17, 2022
The latest release of Pfizer-BioNTech COVID-19 vaccine documents raises questions about how frequently adverse events experienced by clinical trial participants were reported as “unrelated” to the vaccine.
The 80,000-page document cache released May 2 by the U.S. Food and Drug Administration (FDA) includes an extensive set of Case Report Forms (CRFs) from Pfizer trials conducted at various locations in the U.S.
The documents also include the “third interim report” from BioNTech’s trials conducted in Germany (accompanied by a synopsis of this report and a database of adverse events from this particular set of trials).
The FDA released the documents, which pertain to the Emergency Use Authorization (EUA) of the vaccine, as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act (FOIA) request filed in August 2021.
Public Health and Medical Professionals for Transparency, a group of doctors and public health professionals, submitted the FOIA request.
Adverse events during Pfizer vaccine trials in the U.S. usually reported as ‘unrelated’ to vaccination
Pfizer conducted a series of vaccine trials at various locations in the U.S., including the New York University Langone Health Center, Rochester Clinical Research and Rochester General Hospital (Rochester, New York) and the J. Lewis Research, Inc. Foothill Family Clinic (Salt Lake City, Utah).
The Pfizer documents released this month by the FDA included a series of CRFs for patients who suffered some type of adverse event during their participation in the COVID-19 vaccine trials.
As the documents reveal, despite the occurrence of a wide range of symptoms, including serious cardiovascular events, almost none were identified as being “related” to the vaccine.
Such serious yet “unrelated” adverse events included:
- Acute asthma exacerbation
- Aortic aneurysm (listed as a pre-existing condition)
- Appendicitis (requiring hospitalization)
- Atrial defibrillation
- Cardiac arrest and acute respiratory failure, requiring hospitalization, sustained by a patient who then was “lost” (could not be located for continued participation in the trial)
- Chest pain (requiring hospitalization, later listed as cardiac ischemia)
- Coronary artery occlusion (listed as both serious and life-threatening)
- Injuries sustained from a fall
- Intermittent non-cardiac chest pain (requiring hospitalization)
- Left breast cancer (listed as a pre-existing occult malignancy)
- Neuritis (peripheral nerve Injury), listed as “unrelated” to the vaccine but related to the blood draw during vaccination
- Pulmonary embolism and bilateral deep venous thrombosis
- Respiratory failure (requiring hospitalization)
- Right ureteropelvic junction obstruction (requiring hospitalization, listed as congenital)
- Small bowel obstruction, listed as “unplanned,” and a panic attack
Of the CRFs found in the documents released this month, only one adverse event is clearly specified as being related to the vaccination: a participant who suffered from psoriatic arthritis, with no prior history of the condition.
In addition, several CRFs indicated exposure during pregnancy (see here and here), or during a partner’s pregnancy (see here and here). However, the documents provided do not appear to have provided any follow-ups regarding any outcomes or potential adverse events for the participants, their partners or their newborn babies once born.
In some instances, while the CRFs claimed the adverse events suffered by patients were not related to the vaccine, their cause was unspecified, simply indicated as “other,” while in another case, a participant’s “unplanned” small bowel obstruction and panic attacks were listed as being unrelated to the vaccination despite no relevant medical history pertaining to the SAEs (severe adverse events) in question.
Did Pfizer hide critical information from regulators?
It is difficult to draw concrete conclusions about any specific case from the data provided by CRFs and vaccine trial summaries.
However, what raises eyebrows is the very large number of adverse events — often serious and often requiring the hospitalization of the patients involved — that were determined to be “unrelated” to the administration of the COVID vaccine.
Previously released Pfizer documents also included discrepancies in the recording of adverse events.
According to investigative journalist Sonia Elijah, these discrepancies include:
- Trial participants were entered into the “healthy population” but were, in actuality, far from healthy.
- SAE numbers were left blank.
- Barcodes were missing from samples collected from trial participants.
- The second vaccine dose was administered outside the three-week protocol window.
- New health problems were dismissed as “unrelated” to the vaccination.
- A remarkable number of patients with an observation period of exactly the same duration — 30 minutes, with very little variety in observation times and raising questions as to whether patients were adequately observed or were put at risk.
- Oddities pertaining to the start and end dates of SAEs – for instance, a “healthy” diabetic suffered a “serious” heart attack on October 27, 2020, but the “end” date for this SAE is listed as the very next day, even though the patient was diagnosed with pneumonia that same day.
- Impossible dating: in the aforementioned example of the patient who sustained a heart attack and pneumonia, the individual in question later died, but the date of death is indicated as the day before the patient was recorded as having gone to a “COVID ill” visit.
- Unblinded teams, who were aware of which patients received the actual vaccine or a placebo, were responsible for reviewing adverse event reports, potentially leading to pressure to downplay COVID-related events in the vaccinated, or to indicate that adverse events were related to the vaccine.
- Other adverse events were indicated as “not serious” despite extensive hospital stays, of up to at least 26 days in the case of one patient who suffered a fall which was classified as “not serious,” yet facial lacerations sustained as a result of the fall were attributed to hypotension (low blood pressure).
Many of these practices seem to appear in the trial-related documents released this month.
Medical and scientific experts who spoke to The Defender expressed similar concerns about what this month’s tranche of documents reveals, and addressed cases of “disappearing” adverse events.
Brian Hooker, chief scientific officer for Children’s Health Defense, remarked:
“I’m most concerned about ‘disappearing’ patients. One cannot conduct a valid trial and simply omit the results that they don’t like!
“With the stories about Maddie de Garay and Augusto Roux surfacing, I have to wonder how many other participants were dropped in order to hide vaccine adverse events/effects.
“If you look at the data in VAERS [Vaccine Adverse Event Reporting System], COVID-19 vaccines are the most dangerous ever introduced into the population.”
Dr. Madhava Setty, a board-certified anesthesiologist and senior science editor for The Defender, said:
“The ‘unrelated’ label the investigators use to divert attention from AEs [adverse events] is a powerful point that stands on its own. We haven’t pushed back on this enough.
“Equivalently, we can say that the meager and short-lived benefit of these shots is also ‘unrelated’ using their ‘standards.’ On what grounds can they say that their product is preventing infection (which it isn’t anymore), or death (marginally)?
“They cannot have it both ways. They cannot claim a benefit through short-term outcomes while denying that side effects of any kind are related to their product.
“That’s the whole point of doing a trial. You cannot prove causation, only statistically significant correlation.”
Setty provided further context for his remarks in an April 2022 article for The Defender and in a March 2022 presentation, in which he discussed the number of these adverse events and how Pfizer swept them away (timestamp 24:00).
In Setty‘s view:
“There’s a high likelihood of malfeasance going on. [Pfizer whistleblower] Brook Jackson says the PIs [principal investigators] were unblinded. If true, it would make it very easy for the investigators to bump up the AEs in the placebo group while ignoring some of the AEs in the vaccine group.
“Pfizer claims that 0.5% of placebo recipients suffered a serious adverse event compared to 0.6% in the vaccine group. This is how these events were obscured.”
The extant body of evidence indicates Pfizer “is hiding critical information from regulators,” Setty said:
“The clincher is in the memorandum to the VRBPAC [Vaccines and Related Biological Products Advisory Committee] (Table 2, efficacy populations), where they show us that five times more people in the vaccine group were pulled out of the trial than the placebo within seven days of their second shot for ‘important protocol deviations.’
“In a trial that big the chances that could have happened coincidentally is infinitesimally small (less than 1 in 100,000).
“Moreover, months later, the same thing happened in the pediatric trial (Table 12). This time, six times more children were pulled from the trial after their second dose.
“There are, of course, procedural differences when administering a placebo versus the mRNA vaccine, but why didn’t it happen after the first dose as well?
“Mathematically, that is about as close as you can get to eliminating any ‘shadow of doubt.’ With a formal allegation by a trial coordinator that states the same thing [referring to whistleblower Brook Jackson], we can be assured Pfizer is hiding critical information from regulators.”
BioNTech trials in Germany claim few adverse events ‘related’ to vaccine
The BioNTech trial in Germany tested various dosages of two COVID-19 vaccine formulas, labeled BNT162b1 and BNT162b2 — the latter granted EUA by the FDA.
The latest cache of Pfizer documents suggests a pattern, similar to the one in the U.S. trials, of not reporting adverse events as related to the vaccine.
According to the third interim report, dated March 20, 2021, among trial participants who were administered the BNT162b2 candidate vaccine granted EUA in the U.S.:
- 87% of younger participants reported solicited local reactions, and 88% reported solicited systemic reactions, with 10% reporting solicited systemic reactions of Grade 3 or higher.
- 87% of younger participants experienced “mild” solicited local reactions, and 35% experienced “moderate” solicited local reactions.
- 88% of younger participants experienced “mild” solicited systemic reactions, and 38% experienced “moderate” solicited systemic reactions. As stated in the report:
“The most frequently reported solicited systemic reactions of any severity were fatigue (n=40, 67%), followed by headache (n=32, 53%), malaise (n=24, 40%), and myalgia (n=23, 38%). The remaining symptom terms were less frequent.
“For nausea, headache, fatigue, myalgia, chills, arthralgia and malaise each symptom was assessed as severe in <10% of participants.”
- 43% of younger participants reported a total of 51 unsolicited TEAEs (treatment-emergent adverse events, referring to conditions not present prior to treatment or that worsened in intensity after treatment) within 28 days of the first or second dose, nine of which were deemed to be “related” to the vaccination. One participant in this category sustained a TEAE assessed as Grade 3 or higher, but “which was assessed as not related by the investigator.”
- TEAEs among younger participants included hypoaesthesia, lymphadenopathy, heart palpitations, external ear inflammation, blepharitis, toothache, non-cardiac chest pain, cestode infection, oral herpes, tonsillitis, neck pain, insomnia, anosmia and dysmenorrhea.
- No unsolicited treatment-emergent serious adverse events (TESAEs) or deaths were reported among younger participants, but one discontinued participation due to moderate nasopharyngitis.
- One younger participant “discontinued due to a moderate AE (nasopharyngitis).”
- 86% of older participants reported solicited local reactions, with 6% reporting solicited local reactions of Grade 3 or higher, 78% reporting “mild” solicited local reactions and 36% reporting “moderate” solicited local reactions.
- 72% of older participants reported solicited systemic reactions, with 11% of these participants sustaining solicited systemic reactions of Grade 3 or higher, 69% sustaining “mild” solicited reactions and 36% sustaining “moderate” solicited reactions.
- 33% of older participants reported a total of 20 unsolicited TEAEs, four of which were determined to be “related” to the vaccination. Among older participants, 8% reported a TESAE of Grade 3 or higher, with “one event assessed as related by the investigator.”
- One older participant was reported to have sustained a “not related TESAE” (an ankle fracture).
- TESAEs among older participants included back pain, chest pain, facial injury, increased lipase, increased amylase, muscle spasms, musculoskeletal pain, tendon pain, orthostatic intolerance, renal colic, seborrhoeic dermatitis and “painful respiration.”
Among trial participants who received the BNT162b1 candidate vaccine (not granted EUA):
- 86% of “younger participants” reported solicited (expected) localized reactions (remaining in one part of the body), with 18% reporting Grade 3 or higher solicited local reactions, 86% of younger participants reporting “mild” solicited local reactions and 54% reporting “moderate” solicited local reactions.
- 92% of younger participants reported solicited systemic reactions (spreading to other parts of the body), with 44% reporting Grade 3 or higher solicited systemic reactions, 90% reporting “mild” solicited systemic reactions and 74% experiencing “moderate” solicited systemic reactions.
The report states:
“The most frequently reported solicited systemic reactions of any severity were fatigue (n=68, 81%), headache (n=66, 79%), myalgia (n=51, 61%), malaise (n=50, 60%), and chills (n=47, 56%). The remaining symptom terms were less frequent.
“For nausea, vomiting, diarrhea, myalgia, arthralgia and fever each symptom was assessed as severe in ≤10% of participants.”
- 45% of younger participants reported a total of 83 unsolicited (unexpected) TEAEs within 28 days of receiving the first or second dose.
A total of 51 of these unsolicited TEAEs were reported as “related” to the vaccination, while 2% of participants sustained Grade 3 or higher TEAEs (four in total), “of which three events were assessed as related by the investigator.”
No unsolicited TESAEs or deaths were reported in this category.
- According to the report, among younger participants, TEAEs included:
“‘General disorders and administration site conditions’ reported by 9 participants (11%),” including influenza-like illness and injection site hematoma.
“‘Nervous system disorders’ reported by 10 participants (12%),” including presyncope, hyperaesthesia, paraesthesia, and headache.
“‘Respiratory, thoracic and mediastinal disorders’ reported by 9 participants (11%),” including cough and oropharyngeal pain.”
Other symptoms included back pain, musculoskeletal chest pain, cervicobrachial syndrome, taste disorder, sleep disorder, depression, hallucination, dysmenorrhoea, pruritus and pityriasis rosea, while one participant required the excision (removal) of a papilloma.
- One younger participant discontinued participation in the trial, “due to a moderate AE (malaise),” while another participant discontinued participation “due to dose-limiting toxicity.”
- 83% of “older participants” reported solicited local reactions, but none were reported as Grade 3 or higher, while 83% of solicited local reactions were “mild” and 42% were “moderate.”
- 92% of older participants reported solicited systemic reactions, with 28% of participants experiencing Grade 3 or higher solicited systemic reactions, 89% experiencing “mild” solicited systemic reactions, and 61% experiencing “moderate” solicited systemic reactions.
According to the report:
“The most frequently reported solicited systemic reactions of any severity were headache (n=29, 81%), fatigue (n=27, 75%), myalgia (n=18, 50%), and malaise (n=18, 50%). The remaining symptom terms were less frequent.”
- 36% of participants reported a total of 24 unsolicited TEAEs within 28 days of the first or second dose, nine of which were assessed as “related” to the vaccination.
Of the participants in this category, 11% reported TEAEs of Grade 3 or higher (four events in total), with one of these events assessed as “related” to the vaccination.
- TEAEs reported by older participants included oropharyngeal pain, nasopharyngitis, bladder dysfunction, sleep disorder, musculoskeletal pain and musculoskeletal chest pain, pollakiuria, migraine, syncope and alopecia.
- One older participant receiving the BNT162b1 candidate sustained a TESAE (syncope), and there were no deaths in this category.
Of note, none of the participants for either vaccine candidate were pregnant, which raises questions about recommending and administering the vaccine to pregnant women despite the absence of any clinical trial data.
As the documents show, a wide range of adverse effects were reported, including cardiovascular and nervous system conditions, most of which were determined to be unrelated to the vaccination itself.
Michael Nevradakis, Ph.D., is an independent journalist and researcher based in Athens, Greece.
© 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
Monkeypox Fears May Rescue Endangered Corporations
By Whitney Webb |
Unlimited Hangout| May 20, 2022
In recent days, concern over a global outbreak of monkeypox, a mild disease related to smallpox and chickenpox, has been hyped in the media and health ministries around the world, even prompting an emergency meeting at the World Health Organization (WHO). For some, fears have centered around monkeypox being the potential “next pandemic” after Covid-19. For others, the fear is that monkeypox will be used as the latest excuse to further advance draconian biosecurity policies and global power grabs.
Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.
For these companies, the monkeypox fears are a godsend, specifically for SIGA, which produces a smallpox treatment, known by its brand name TPOXX. It is SIGA’s only product. While some outlets have noted that the rise in the valuation of SIGA Technologies has coincided with recent concerns about monkeypox, essentially no attention has been given to the fact that the company is apparently the only piece of a powerful billionaire’s empire that isn’t currently crumbling.
That billionaire, “corporate raider” Ron Perelman, has deep and controversial ties to the Clinton family and the Democratic party as well as troubling ties to Jeffery Epstein. Aside from his controlling stake in SIGA, Perelman has recently made headlines for rapidly liquidating many of his assets in a desperate bid for cash.
Similarly, Emergent Biosolutions has also been in hot water. The company, which has troubling ties to the 2001 Anthrax attacks, came under fire just under two weeks ago for engaging in a “cover up” over quality control issues relating to their production of Covid-19 vaccines. A Congressional investigation found that quality control concerns at an Emergent-run facility led to more than 400 million doses of Covid-19 vaccines being discarded. The Emergent factory in question had been shut down by the FDA in April 2021. They were allowed to reopen last August before the government terminated the contract. Given that the majority of the company’s business is tied to US government contracts, the loss of this contract, and the accompanying poor publicity, the news that its smallpox vaccine may soon be of international interest is likely seen as a godsend by the company.
Notably, this is the second time in a year that both companies have benefitted from pandemic or bioterror fears propagated by the media. Last November, speculation rose that a re-emergence of the eradicated virus that causes smallpox would soon take place. This first began with Bill Gates’ comments on the prospects of smallpox bioterrorism during a November 4th, 2021 interview and was followed by the November 16th announcement of a CDC/FBI investigation into 15 suspicious vials labeled “smallpox” at a Merck facility in Philadelphia. Now, roughly six months later, the same fears are again paying off for the same two companies.
A Killer Enterprise
Emergent Biosolutions was previously known as BioPort. The company was founded by Fuad el-Hibri, a Lebanese businessman, who leveraged his contacts with powerful US former military officials and politicians, to take control of a flailing Michigan factory. It was the only factory authorized to produce an anthrax vaccine.
The anthrax vaccine was known to have major problems even before BioPort had acquired it, and is believed by many investigators to be one of the main causes of “Gulf War” syndrome. The vaccine itself, originally developed at Fort Detrick, had little to no safety track record at the time it was administered to US troops in the First Gulf War – a problem that was never remedied. However, its chronic safety issues and its clumsy, multi-dose regimen would later prompt BioPort/Emergent Biosolutions to spend years developing a new formulation of its anthrax vaccine.
The creation of BioPort coincided with the Clinton administration’s efforts to mandate the anthrax vaccine for all members of the US Armed Forces. With control over the only source of anthrax vaccine, BioPort was poised to make a killing.
Once the company acquired the Michigan facility, it took large amounts of US government funds, ostensibly to make improvements at the site. However, the company declined to use the funds to make the necessary repairs, instead spending that money on its executives’ offices, as opposed to the vaccine factory, and millions more on bonuses for “senior management.” Pentagon auditors would later find that still millions more had gone “missing” and BioPort’s staff were unaware of the cost of producing a single dose of the vaccine. Despite the clear mismanagement and corruption, BioPort demanded to be bailed out by the Pentagon, and they were. Meanwhile, the Michigan facility lost its license after a government inspection found numerous safety issues.
However, by August 2001, BioPort stood to lose the Pentagon contracts – its only source of income. The Pentagon began preparing a report, due to be released in September 2001, that would detail a plan for letting BioPort go. Thanks to the September 11, 2001 attack on the Pentagon, that report was never released. Shortly thereafter, the 2001 anthrax attacks began.
Just months before, BioPort had contracted Battelle Memorial Institute to help rescue its flailing vaccine program. The deal gave Battelle “immediate exposure to the vaccine” and it was used in connection with the Pentagon-funded, gain-of-function anthrax program that involved both Ken Alibek and William C. Patrick III, two bioweapons experts with deep ties to the CIA. That program was housed at Battelle’s West Jefferson facility in Ohio. That facility is believed by many investigators to be the source of the anthrax used in the 2001 attacks.
The ensuing panic from the anthrax attacks led the Department of Health and Human Services (HHS) to intervene. They gave BioPort its license back in January 2002 despite persisting safety concerns at its vaccine production facility in Michigan. BioPort was not content to merely see its past contracts with the Pentagon restored, however, as it began lobbying heavily for new contracts for anthrax vaccines intended for American civilians, postal workers and others. They would get them, largely thanks to HHS’ then-counter-terrorism adviser and soon to be HHS’ newest Assistant Secretary — Jerome Hauer. Hauer would later join the board of BioPort, after it reformed as Emergent Biosolutions, in 2004.
Such examples of cronyism are more common than not when it comes to Emergent Biosolutions. Indeed, the company has frequently relied on individuals who spend their careers passing through the “revolving door” between the pharmaceutical industry and government, particularly those who also moonlight as bioterror alarmists. One of the main individuals critical to the company’s success over the years has been Robert Kadlec. Kadlec served as the top bioterror advisor to the Pentagon in the weeks leading up to the 2001 anthrax attacks. Months prior, he had participated in the June 2001 simulation Dark Winter, which “predicted” major aspects of the subsequent anthrax attacks. Kadlec subsequently crafted much of the legislation that would create the country’s subsequent bioterror/pandemic response policy, including BARDA and the Strategic National Stockpile.
Soon after leaving government, Robert Kadlec helped found a new company in 2012 called “East West Protection,” which develops and delivers “integrated all-hazards preparedness and response systems for communities and sovereign nations.” The company also “advises communities and countries on issues related to the threat of weapons of mass destruction and natural pandemics.”
Kadlec formed the company with W. Craig Vanderwagen, the first HHS Assistant Secretary for Preparedness and Response (a position Kadlec had helped write into law and would later hold himself). The other co-founder of East West Protection was Fuad El-Hibri, the founder of BioPort/Emergent Biosolutions, who had just stepped down as Emergent’s CEO earlier that year.
Kadlec then became a consultant. Kadlec’s consultancy firm, RPK Consulting, netted him $451,000 in 2014 alone, where he directly advised Emergent Biosolutions as well as other pharmaceutical companies like Bavarian Nordic. Kadlec was also a consultant to military and intelligence contractors, such as the DARPA-backed firm Invincea and NSA contractor Scitor, which was recently acquired by SAIC.
Kadlec would return to government as HHS ASPR under Trump, a position which he held at the time the Covid-19 crisis began. The year prior, in 2019, Kadlec had conducted a months-long simulation focused on a global pandemic originating in China called Crimson Contagion. Once the Covid-19 crisis began in earnest, he played a major role in securing Covid-19 vaccine contracts for Emergent Biosolutions, despite his conflicts of interest, some of which he had declined to disclose upon being appointed to serve as ASPR.
Emergent Biosolutions’ pattern of corrupt behavior, beginning with its anthrax vaccine, can be seen with its recent actions as it relates to its production of Covid-19 vaccines. Per the recent Congressional report, released just days before the recent spike in concern over monkeypox began, Emergent lab workers “intentionally sought to mislead government inspectors about issues” at its Baltimore-based plant and also repeatedly “rebuffed” efforts by AstraZeneca and Johnson & Johnson to inspect their facilities. “Despite major red flags at its vaccine manufacturing facility, Emergent’s executives swept these problems under the rug and continued to rake in taxpayer dollars,” House Oversight and Reform Committee Chairwoman Carolyn Maloney (D-NY) stated upon the report’s release. Yet such “major red flags” can be found throughout the company’s entire history, for those willing to take the time to look.
Just days after the Congressional report was released, Emergent Biosolutions announced that it would acquire the exclusive worldwide rights to the “first FDA-approved Smallpox Oral Antiviral for all ages” from the company Chimerix. The drug, called TEMBEXA, is only for the treatment of smallpox, which the company refers to as “a high priority public health threat.” The press release on the company’s acquisition of TEMBEXA states that multi-million US government contracts for the product are anticipated. The FDA formally approved the drug last June.
Emergent Biosolutions also has the rights to the smallpox vaccine known as ACAM2000, which can also be used to treat monkeypox. The vaccine, originally produced by Sanofi, was acquired by the company in 2017. As a result, the company has an essential monopoly over smallpox vaccines as ACAM2000 is “the only vaccine licensed by the FDA for active immunization against smallpox disease for people determined to be at high risk of smallpox infection.”
Given their track record, it’s worth asking why Emergent Biosolutions has been working in recent months to pivot much of its business into smallpox treatments. However, there is no speculation needed when observing that the current monkeypox fears and helping rescue the company, whose shares had fallen some 26% year to date before concern over the recent monkeypox outbreak began to grow.
Whatever comes of the monkeypox situation, Emergent Biosolutions’ decades-long track record is undeniably one of corruption and cronyism.
“BioArmor” for Ron Perelman’s Flailing Business Empire
SIGA Technologies, which likens its products to “Human BioArmor”, features a quote from Bill Gates at the top of its about page. The quote reads: “[…] the next epidemic could originate on the computer screen of a terrorist intent on using genetic engineering to create a synthetic version of the smallpox virus […]” The quote is from Bill Gates’ speech to the 2017 Munich Security Conference, where he used the threat specifically of smallpox to argue that “health security” and “international security” be merged. Notably, last March, the Munich Security Conference hosted a simulation of a global pandemic caused by a “genetically engineered monkeypox virus.”
SIGA is one example of a company that seeks to find its niche in the middle of “health security” and “international security.” It specifically provides “solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats, as well as emerging infectious diseases.” The majority of contracts for CBRN medical countermeasures in the US are funded by the Pentagon. While it promotes itself as a CBRN threat-focused company, SIGA is, for now, singularly focused on smallpox.
Indeed, SIGA Technologies is only currently profitable in the event of an actual outbreak of smallpox or a related disease, or when fear of a smallpox bioterror event is high. Specifically, concern over the latter has led to the company to win government contracts to produce TPOXX for the Strategic National Stockpile (SNS). This is because TPOXX is only used to treat active smallpox or monkeypox infection, not prevent it. This means that it is only useful if smallpox, monkeypox or a related disease is actively infecting people or if there is a high risk that one of these diseases will soon infect large groups of people. TPOXX was first approved in 2018 by the FDA and was approved by the European Medicine Agency (EMA) this past January. The FDA approved an intravenous version of TPOXX just this past Thursday. Overall, SIGA has received over $1 billion from the US government to develop TPOXX.
SIGA is currently partnered with HHS’ BARDA, the Department of Defense, the CDC and the NIH. Another partner is Lonza, a European pharmaceutical manufacturing firm that is partnered with both the World Economic Forum and Moderna. SIGA’s CEO, Phillip Gomez, is an alumni of PRTM Consulting, where he would have worked closely with Robert Kadlec, as the two men overlapped as directors of the firm and both worked advising government agencies on matters of public health and biodefense.
SIGA is also notable because it is possibly the only company in the business empire of corporate raider Ron Perelman that is not attached to growing mountains of debt. Perelman is one of the notorious corporate raiders from the 1980s who conducted corporate takeovers fueled by junk bonds, particularly those connected to Michael Milken’s Drexel Burnham Lambert. Perelman’s business tactics have long been informed by his volcanic temper and his ruthlessness, with former Salomon Brothers CEO John Gutfruend once remarking that “believing Mr. Perelman has no hostile intentions is like believing the tooth fairy exists.”
Perelman is also known for being a long-time patron of the Clinton family, even though, more recently he donated to Donald Trump’s political campaigns. Perelman apparently first became interested in courting influence with the Clintons after marrying Patricia Duff in 1994. Duff was deeply connected to the Democratic Party, having worked for Democratic pollster Pat Cadell, and she had also worked for the House panel that “investigated” the assassinations of John F. Kennedy and Martin Luther King Jr. Prior to marrying Perelman, she had been married to movie mogul Michael Medavoy and had “introduced Clinton to the Hollywood establishment,” according to the Washington Post.
As Perelman’s wife, Duff styled herself a leading Democratic fundraiser, with the 1995 fund-raising dinner being emblematic of that. Also, in 1995, Perelman attended a $1,000-a-plate dinner in New York for the Clintons, where Perelman sat across from the President, as well as a state dinner for Brazil’s president at the White House.
For Perelman, his generosity to the Clinton political machine resulted in an appointment by Clinton to the board of trustees of the Kennedy Center in 1995. Other, less public gestures from the Clintons were likely, as Perelman offered much more to the First Family than he appears to have received in return. Perhaps most notable of Perelman’s favors for Bill Clinton was his offering of jobs to scandal-ridden members of his administration, Webster Hubbell and Monica Lewinsky, in the wake of their respective controversies. However, after the job offers were publicly reported, both Hubbell and Lewinsky were let go, though the offers later caught the attention of independent counsel Ken Starr. Starr never subpoenaed or investigated Perelman or the offers he had made to Hubbell or Lewinsky.
The controversial hirings had been arranged between Perelman and Clinton advisor Vernon Jordan, who sat on the board of Revlon, a Perelman-controlled company, while his wife was on the board of another Perelman-owned firm. Jordan was known as Clinton’s “conduit to the high and mighty” and had taken Clinton to the 1991 Bilderberg conference. On the decision to hire Lewinsky following the scandal, a former business associate of Perelman’s told the Washington Post that “It’s like the Mafia, it’s all done in code,” adding that “I can assure you that Ronald made the decision to give Lewinsky the job. And I can assure you he wouldn’t want to know why Jordan was asking.”
In 1995, Perelman held a Clinton fundraiser at his mansion, with guests including singer Jimmy Buffett, Miami Vice actor Don Johnson, actor Michael Douglas’ then-wife Deandra and DNC co-chair Don Fowler. Other guests included A. Paul Prosperi, a corrupt Clinton crony, and the now infamous Jeffrey Epstein. Clinton himself attended the fundraiser. According to the Palm Beach Post, guests had donated at least $100,000 to the DNC to attend the dinner with the President. This was, of course, in the lead up to the 1996 election, and the DNC would later come under heavy scrutiny due to illegal fundraising. This fundraiser was not Epstein’s only interaction with Perelman – Perelman would later be listed as a frequent dinner guest of Epstein’s in the 2003 Vanity Fair profile penned by Vicky Ward and is listed in Epstein’s black book of contacts.
For most of the 2000s, Perelman has sat atop a massive, ever-growing fortune. Yet, since 2020, Perelman has “been unloading assets ‘A lot of them. Rapidly.’” It started with sales of valuable paintings at Sotheby’s and soon extended to Perelman’s investment company MacAndrews & Forbes, which disposed of its interest in two companies that same year, including $1 billion in shares in Scientific Games. According to MoneyWeek, Perelman’s net worth dropped from $19 billion in 2018 to $4.2 billion in late 2020, “prompting speculation that he’s running out of money.” Over the course of last year, Perelman has continued to “downsize”, looking to sell off his estate in the Hamptons for $115 million, another 57-acre estate worth $180 million and two townhouses in Manhattan’s Upper East Side for $60 million.
Other assets held by Perelman’s company MacAndrews & Forbes are also drowning in debt. One of the few assets of the company that isn’t currently haemorrhaging money or struggling with debt is its shares in SIGA Technologies. Perelman’s main company, MacAndrews & Forbes, has long been one of SIGA’s biggest investors and remains its largest shareholder, controlling 33% of all shares.
Since Perelman got involved with SIGA, accusations of corruption have plagued the company. For instance, in May 2011, SIGA was given a no-bid contract worth about $433 million to develop and produce 1.7 million doses of anti-viral drug for smallpox. At the time there was no evidence the smallpox drug in question was capable of treating the disease and there was alarm among some HHS staffers that SIGA’s return on investment from the contract was “outrageous.” The contract began to be investigated over concerns that the contract had been awarded to SIGA precisely because it was controlled by Perelman, who had donated heavily to Barack Obama. At the time, CNN noted the following about Perelman’s connections to the Obama White House:
“Ronald Perelman is controlling shareholder of Siga Technologies and a longtime Democratic Party activist and fundraiser. He’s also a large contributor to Republicans, but has been a particular friend of the Obama White House.
Also on Siga’s board of directors is Andy Stern, former president of the Service Employees International Union, who has had close relations with the Obama administration and who has supported President Barack Obama’s health care initiatives.”
As a result of these concerns and the potential conflict of interest, a congressional investigation began. Days after learning that this key government contract may be in jeopardy, SIGA executives sold off large amounts of company stock at an average price of $13.46 per share, netting its Chief Executive Officer and Chief Scientific Officer at the time millions of dollars. A month later, the company announced that its contract had been downsized and shares in the company fell to under $2 by that December.
Given past “pay-to-play” accusations around Perelman’s role in the firm during the Obama administration, when President Joe Biden served as Vice President, what are we to make of the recent media hype around monkeypox? Or concerns raised last year of a bioterrorism event involving smallpox?
Perhaps it’s more important to ask other questions – why has Perelman’s role in SIGA been largely obfuscated or totally ignored by recent reporting on the company? Similarly, why has Emergent Biosolutions’ horrific track record also been excluded from recent reports, including the major complaints from Congress made against the company less than two weeks ago? It seems the fear being generated around monkeypox is not only boosting shares for these two rotten companies, it’s helping the public forget their past sins.
Whitney Webb has been a professional writer, researcher and journalist since 2016. She has written for several websites and, from 2017 to 2020, was a staff writer and senior investigative reporter for Mint Press News. She currently writes for The Last American Vagabond.
Pandemic 2: Monkeypox Madness
OffGuardian | May 21, 2022
Monkeypox – it’s the hip new disease sweeping the globe. Allegedly appearing almost simultaneously in over a dozen different countries on four different continents.
As we wrote in the early days of the Covid “pandemic”, the only thing spreading faster than the disease is fear.
The media reported the first UK case of monkeypox on the 7th of May. Less than two weeks later, we’re seeing some very familiar headlines. Just like that…Pandemic 2: Monkey Pox!! begins playing at all your favorite fear porn outlets.
Sky News tells us that UK Monkeypox “cases” have “doubled(!)”… from 10 to 20.
The BBC went real subtle with it, blaring: “Monkeypox: Doctors concerned over impact on sexual health”
The New Scientist has actually used the P-word, asking “Can Monkeypox become a new pandemic?”, before answering, essentially, “probably no, but also maybe yes!”. Keeping their options open.
Science warns that “Monkeypox outbreak questions intensify as cases soar”
The Mirror has gone full paranoid already, headlining:
Russia looked into using monkeypox as biological weapon, claims ex soviet scientist
So that’s one direction the story might go.
To be clear, “monkeypox” (whatever that even means in this context), is NOT a Russian bio-weapon. It’s not a Western bio-weapon either. Or Chinese bio-weapon. It’s just another scare story. And a rushed, half-hearted one at that.
One of the signs that marked the Covid “pandemic” as a psy-op from an early stage was the sheer speed with which the hysteria spread. Far from learning from their mistakes, the powers-that-be have decided to go even faster this time.
Despite “cases” numbering barely in the dozens, the World Health Organization has called an emergency meeting, a strange thing to do when their annual Assembly starts literally tomorrow. But I guess when your launching a new product you need to do everything you can to get the hype going.
Despite just two “cases” in the entire United States (and indeed the fact they still don’t work), New York is bringing back mask recommendations.
Nobody has said “lockdown”… yet. But Hans Kluge, WHO regional director for Europe, is “concerned” that transmission could accelerate if people attend mass gatherings:
as we enter the summer season … with mass gatherings, festivals and parties, I am concerned that transmission could accelerate”.
(As inflation soars and the cost of living crisis only gets worse, it’s probably handy for them to have a new “public health” reason to ban protests or clampdown on civil unrest. Just a thought.)
There’s some good news though… for vaccine manufacturers, anyway. As Whitney Webb reports, two struggling pharmaceutical companies have already seen a big stock boost from the “outbreak”:
Regardless of how the monkeypox situation plays out, two companies are already cashing in. As concern over monkeypox has risen, so too have the shares of Emergent Biosolutions and SIGA Technologies. Both companies essentially have monopolies in the US market, and other markets as well, on smallpox vaccines and treatments. Their main smallpox-focused products are, conveniently, also used to protect against or treat monkeypox as well. As a result, the shares of Emergent Biosolutions climbed 12% on Thursday, while those of SIGA soared 17.1%.
Just as with Covid, and despite rumours they would be leaving the World Health Organization, Russia appears to be lining up with the WHO agenda. Already they are “tightening border quarantine” rules, vaccinating healthcare workers and supplying quick bedside tests internationally.
Looks like we might be in for an epic summer of scare-mongering, panic-buying & bucketloads of cringe.
💢Are the new jabs already prepped & ready to go?
💢Are the “our hospitals are overwhelmed videos” being filmed as we speak, complete with “monkey pox” moulage and crying nurses who turn out to have IMDB pages & multiple acting credits?
💢Are the sleepy masses going to be fooled yet again?
Watch this space…
The WHO Changes Guidelines to Favor Lockdowns
BY WILL JONES | BROWNSTONE INSTITUTE | MAY 18, 2022
The World Health Organisation intends to make lockdowns and other non-pharmaceutical interventions intended to curb viral spread part of official pandemic guidance.
The revelation comes in a report scheduled to go to the WHO’s World Health Assembly later this month. This is not part of new pandemic treaty and does not require the endorsement of member states. The report says the implementation is already underway.
Many have raised the alarm about a new WHO pandemic treaty. However, as I’ve noted previously (and as Michael Senger notes here), there isn’t a new pandemic treaty on the table. Rather, there are amendments to the existing treaty, the International Health Regulations 2005, plus other recommendations (131 in all) put forward in a report from the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies.
Most of these amendments and recommendations relate to information and resource sharing and preparation for future pandemics; none of them directly interferes with state sovereignty in the sense of allowing the WHO to impose or lift measures. However, that doesn’t mean they’re not dangerous, as they endorse and codify the awful errors of the last two years, beginning with China’s Hubei lockdown on January 23rd 2020.
The recommendations in the report originate from WHO review panels and committees and were sent out in a survey in December 2021 to member states and stakeholders to seek their views.
Non-pharmaceutical interventions appear three times in the recommendations, once under “equity” and once under “finance,” where states are urged to ensure “adequate investment in” and “rapid development, early availability, effective and equitable access to novel vaccines, therapeutics, diagnostics and non-pharmaceutical interventions for health emergencies, including capacity for testing, scaled manufacturing and distribution”.
While rapid development and early availability of non-pharmaceutical interventions sounds worrying in itself, it could be interpreted in a number of ways by states.
Where it really gets alarming, however, is in the “leadership and governance” section. LPPPR 29 states (emphasis added):
Apply non-pharmaceutical public health measures systematically and rigorously in every country at the scale the epidemiological situation requires. All countries to have an explicit evidence-based strategy agreed at the highest level of government to curb COVID-19 transmission.
The requirement that a country’s pandemic strategy must aim to curb viral transmission is a major change from the current guidance. The U.K.’s existing pandemic preparedness strategy, prepared in line with previous WHO recommendations, is completely clear that no attempt should be made to stop viral transmission as it will not be possible and will waste valuable resources:
It will not be possible to halt the spread of a new pandemic influenza virus, and it would be a waste of public health resources and capacity to attempt to do so.
It almost certainly will not be possible to contain or eradicate a new virus in its country of origin or on arrival in the U.K. The expectation must be that the virus will inevitably spread and that any local measures taken to disrupt or reduce the spread are likely to have very limited or partial success at a national level and cannot be relied on as a way to ‘buy time’.
It will not be possible to stop the spread of, or to eradicate, the pandemic influenza virus, either in the country of origin or in the U.K., as it will spread too rapidly and too widely.
But now the WHO says that curbing viral transmission is to be the aim of pandemic response. This is a disaster.
Worse, the report says this recommendation will be incorporated into the WHO’s “normative work,” meaning it will be part of official WHO guidance to states in responding to a pandemic. Worse still, it says it’s already being implemented – it doesn’t need a treaty or the agreement of member states to do this, it’s already happening.
Expect to see new guidance appearing at the international and national levels over the coming months and years which incorporate this presumption that restrictions should be imposed to curb viral spread. This is despite the last two years only confirming the wisdom of the WHO’s previous guidance that this is not possible and not worth the attempt.
This matter must be raised at the highest levels so that lockdowns and other non-pharmaceutical interventions are kept out of all pandemic planning.
Sign the parliamentary petition against the latest moves by the WHO here – now at over 121,000 signatures.
Why the World should be very concerned about New Zealand under the Jacinda government
By Guy Hatchard | Waikanae Watch | May 19, 2022
The New Zealand government relies upon a science body known as Te Punaha Matatini (Centre for Science in Society) whose work is funded directly by the office of the Prime Minister and cabinet.
Yesterday, Te Punaha Matatini published a 21-page document entitled “The Murmuration of Information Disorders” (see attached release from the Science Media Centre) designating those opposed to the government’s pandemic policies as violent right wing insurrectionists planning the weaponised storming of parliament and the execution of public servants, academics, journalists, politicians, and healthcare workers.
This is an utterly false characterisation worthy of the worst excesses of historical propaganda.
This 21-page document, represented to the public as a scientific paper, contains not a single discussion of the scientific concerns being raised in opposition to government pandemic policy.
It omits for example analyses of the government’s own official figures which show that the vaccinated are more vulnerable to infection, hospitalisation, and death than the unvaccinated, a fact that has been deliberately hidden from the public.
Prime Minister Jacinda Ardern introduced yesterday’s Te Punaha Matatini report with the words:
“One day it will be our job to try and understand how a group of people could succumb to such wild and dangerous mis- and disinformation. And while many of us have seen that disinformation and dismissed it as conspiracy theory, a small portion of our society have not only believed it, they have acted upon it in an extreme and violent way that cannot stand. We have a difficult journey in front of us to address the underlying cause.”
Since when do reasonable scientifically-based questions asked of the government in good faith constitute violent insurrection?
I am tempted to think that Ardern could just as well be talking about her own government. The Prime Minister and the social scientists(?) working at Te Punaha Matatini might do well to read the New York Times, (although they probably don’t do so because the official policy of the New Zealand government is to discourage any information that is not sanctioned and edited by themselves).
A NYT article on 10 May 2022 entitled “Emergent Hid Evidence of Covid Vaccine Problems at Plant” reports that
“Emergent BioSolutions, a longtime government contractor hired to produce hundreds of millions of coronavirus vaccine doses, hid evidence of quality control problems from Food and Drug Administration inspectors in February 2021 — six weeks before it alerted federal officials that 15 million doses had been contaminated.”
A reasonable observer might conclude that early (and later) concerns being voiced about vaccine safety were justified, but the New Zealand government is far from reasonable.
A succession of scientific papers published in reputable journals during recent weeks (which we and many others have reported extensively and communicated directly to the government) have in fact fully justified concerns about safety and efficacy, but unbelievably our government is in denial and still moving ahead with propaganda advertising of their mRNA vaccination agenda for all ages and, as today’s Te Punaha Matatini report shows, labelling any opposition as a conspiracy with violent aims.
How Did the Transformation of the NZ Government Come About?
New Zealand has a small population of 5 million, but it has been used to trial new products in order to gauge what the public reaction and acceptance might be in bigger markets overseas. Never more so than during the pandemic. Take up of the Pfizer mRNA Covid vaccination has reached up to 95% of the eligible population.
This has been achieved through a transformation in the style of government, media control, science funding, intellectual standards, and international relations unprecedented in the western world, along with the coercion of draconian employment mandates and the pursuit of dissenters through compliant courts.
This has been engineered under the leadership of a person with a bachelor’s degree in communication who grew up in a strict rural Mormon household and cut her political teeth under the Blair administration in London. In keeping with her upbringing and education, Ardern is a leader who is sure she is right and is prepared to enforce her orthodoxy against all opposition and reason.
Her international perspective is one of unquestioning acceptance of the authority and right to rule of global institutions. Her top confidant and mentor Helen Clark, former NZ Labour Prime Minister, is closely associated with this outlook. Ardern recounts that she begins her day with a discussion with Clark over breakfast.
Like Ardern, Clark is renowned for her iron fist management style. She ruffled feathers at the United Nations Development Programme, which she led from 2009 to 2017, reportedly undermining human rights and supporting China’s Belt and Road initiative.
On 9 July 2020 the World Health Organization (WHO) appointed Clark as co-chair of a panel reviewing the WHO’s handling of the COVID-19 pandemic and the response of governments to the outbreak. The Independent Panel for Pandemic Preparedness and Response (IPPR) examined how the outbreak occurred and how future pandemics can be prevented.
Nothing says more about the overt global agenda of Ardern and Clark than this 11 May 2022 statement of the New Zealand government:
“The establishment of a pandemic treaty/instrument was a key recommendation of the Independent Panel for Pandemic Preparedness and Response and is one of New Zealand’s foremost global health priorities”
Like China, New Zealand’s fading international reputation for successful management of the pandemic was actually built on a single policy—control the borders, restrict entry, and impose lengthy quarantine.
The Current Situation in New Zealand is Deeply Concerning
Ardern controls the media and the science dialogue through a mixture of government funding and exclusion of dissent. The government has spent big on saturation advertising advising complete safety and efficacy of the Pfizer vaccine, and continues to do so.
It has instituted funding of cultural groups, GPs, and commercial organisations who promote vaccination. The level of funding is so generous that it has distorted prior long standing economic and political relationships.
So far the government has spent on the order of $100 billion on the pandemic in addition to normal expenditure. To put this in stark perspective, that is equal to the total annual government budget prior to the pandemic—more than $20,000 for every man, woman, and child. This is borrowed money which will have to be repaid through increased taxation of an already struggling population.
We Have No Constitution in New Zealand, the Power of the Government Is Absolute.
The control that Ardern’s government exercises over the courts, government agencies, parliament, media, independent regulators, and over the vast majority of the population is staggering and rigidly enforced. Dissenting medical professionals are excluded from practicing and in some cases prosecuted also. They are also mercilessly hounded and vilified by bought mainstream media.
In an atmosphere of strict government control, more worrying aspects of information control have emerged. In some cases noted by my scientific colleagues, policy and pronouncements that they have demonstrated are in conflict with published research have disappeared from the public record.
Even rare court rulings in favour of caution have been rapidly bypassed by simply passing new laws without debate. Court rulings about mandates have also been openly flouted, as happened when the military vaccine mandate was ruled illegal. With the support of the government, the military said the courts had no jurisdiction over its operation and went ahead anyway.
Ardern has introduced her policies in such a dedicated, persuasive, secretive, and complete way that almost the whole population of New Zealand has complied. They have accepted limitations on medical choice, judicial protections, human rights, press freedom, freedom of information, privacy, employment conditions and opportunities, standard of living, and social interaction.
Ardern’s successful efforts to persuade the population that government should be your only source of truth, have all but negated any of the longstanding mechanisms of government accountability. A majority of the population have all but concurred with Ardern that the unvaccinated may be safely blamed for every government failing and omission; and for all Covid case loads, hospitalisations, and deaths contrary to all evidence.
The opposition parties have apparently accepted that they will in future go about their business using the same Ardern doctrines and techniques. Accordingly they have failed to sound the alarm, investigate Covid science publishing deeply, or oppose draconian legislation. They have joined Ardern in labelling peaceful protest as unacceptable and illegal.
Ardern on the Global Stage
Ardern is about to deploy her international political capital to promote the globalisation of her policies and outlook. Her public persona can be deceptively mesmerising. You should be worried.
The world’s economy also has no constitution. So far Ardern appears to be happy to allow it to be controlled by global economic predators. Pfizer has been uncritically promoted by her, and the notion of WHO control over New Zealand’s sovereign rights is being welcomed with open arms. It fits with her strict hierarchical perspective.
Ardern may be viewed by naive foreign governments as a pandemic success story unfairly criticised in her own country. Stop for a moment and consider that she is about to lend her support to the promotion of a new world order on the global stage using her trademark persuasive techniques of propaganda, coercion, and control of information.
Featured Video
Douglas Macgregor: No Peace – U.S. Prepares for ‘Total War’ Against Iran
or go to
Aletho News Archives – Video-Images
Book Review
Palantir CEO Calls for Draft to Fight the Empire’s Wars
Involuntary servitude is good for business
By Kurt Nimmo | Another Day in the Empire | April 20, 2026
In 2025, Alex Karp, the CEO of government and military tech contractor Palantir, published The New York Times best-seller, The Technological Republic: Hard Power, Soft Belief, and the Future of the West. The Wall Street Journal praised the book as a cri de coeur, a passionate appeal “that takes aim at the tech industry for abandoning its history of helping America and its allies,” while Wired praised the book as a “readable polemic that skewers Silicon Valley for insufficient patriotism.”
On April 18, 2026, Palantir posted twenty-two points to social media summarizing the book. In addition to taking Silicon Valley to task for insufficient patriotism, advocating a role for AI in forever war, and denouncing the “psychologization of modern politics,” the Palantir post on X declares: “National service should be a universal duty. We should, as a society, seriously consider moving away from an all-volunteer force and only fight the next war if everyone shares in the risk and the cost.”
National conscription, a form of involuntary servitude, and the wars it portends, is good for business, especially for corporations within the orbit of the Pentagon, the CIA, and the national security state. Palantir fits comfortably within this amalgamation. … continue
Blog Roll
Aletho News- Douglas Macgregor: No Peace – U.S. Prepares for ‘Total War’ Against Iran
- How A Fake Iranian Terror Group Was Invented To Proscribe IRGC in Europe
- Iran’s judiciary rejects Trump’s claim on ‘planned execution’ of 8 women
- Israeli army blows up school in southern Lebanon in violation of ceasefire
- The desalination front: Water as Israel’s Achilles heel
- Washington cuts flow of US dollars to Iraqi central bank until ‘acceptable’ government formed
- China blames US for diplomatic impasse with Iran, urges it to show ‘sincerity’ in talks
- Iran announces new Hormuz restrictions after US ceasefire violations
- After Islamabad: How the Global South Is Reshaping Eurasian Geopolitics
- Is Trump Going for Armageddon?
- If Americans Knew
- Israeli soldiers using sexual assault to force Palestinians out of West Bank, report says
- Top Biden Official Supports Trump Iran Attack, Says Biden May Have Done The Same
- A history of Israel’s invasions of Lebanon
- How the powerful pro-Israel lobby keeps controlling Democrats in the US
- Replay: Israel’s slow ethnic cleansing of Christians from the Holy Land
- 5 times Israelis desecrated Christian sites in the past two years
- US running out of weaponry for Israel’s war; Iran has plenty – Daily Update
- Israel is (still) killing aid workers in Gaza
- Catholics finally splitting with Trump over Iran war and Israel
- Israel’s “Black Wednesday” Massacre Leaves Lebanese Families Giving DNA To ID Loved One’s Remains
- No Tricks Zone
- New Study: The Climate May Be 5 Times More Sensitive To Solar Forcing Than Commonly Assumed
- EV Industry Reached $70 Billion In Losses In 2024 Due To Delusional Green Ideologies
- Reality Check: Maldives Have Actually Grown In Size Or Remained Stable Over Recent Decades
- Abrupt Climate Change Also Occurred NATURALLY In The Past …25 Times During Last Ice Age
- Cave Discovery Reveals Today’s Desert Climates Were Recently Far Warmer, Wetter, Teeming With Life
- German Expert: Heat Dome Led To Record Temps In Western USA…Warmer In 1934, 1936
- New Study: No Linear Warming Or Glacier Retreat Along Northern Antarctic Peninsula Since 1980s
- An Inconvenient Tree: Uncovered In Alps… Europe Much Warmer Than Today 6000 Years Ago
- New Study Reports A 60% Slowdown In Greenland’s Ice Loss Rate In The Last Decade
- Low Intensity Tornado Wrecks Major Solar Farm, Creating A Potential Toxic Dump
Aletho News 